SYSTEMIC AVAILABILITY OF ORAL VERAPAMIL AND EFFECT ON PR-INTERVAL IN MAN

被引:49
作者
JOHNSTON, A
BURGESS, CD
HAMER, J
机构
关键词
D O I
10.1111/j.1365-2125.1981.tb01233.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:397 / 400
页数:4
相关论文
共 5 条
[1]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF VERAPAMIL .2. SIMULTANEOUS QUANTITATION OF VERAPAMIL AND ITS ACTIVE METABOLITE, NORVERAPAMIL [J].
HARAPAT, SR ;
KATES, RE .
JOURNAL OF CHROMATOGRAPHY, 1980, 181 (3-4) :484-489
[2]  
KOIKE Y, 1979, RES COMMUN CHEM PATH, V24, P37
[3]   VERAPAMIL IN TREATMENT OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA [J].
KRIKLER, DM ;
SPURRELL, RA .
POSTGRADUATE MEDICAL JOURNAL, 1974, 50 (585) :447-453
[4]   VERAPAMIL AND MYOCARDIUM [J].
NAYLER, WG ;
KRIKLER, D .
POSTGRADUATE MEDICAL JOURNAL, 1974, 50 (585) :441-446
[5]   PHYSIOLOGICAL DISPOSITION OF VERAPAMIL IN MAN [J].
SCHOMERUS, M ;
SPIEGELHALDER, B ;
STIEREN, B ;
EICHELBAUM, M .
CARDIOVASCULAR RESEARCH, 1976, 10 (05) :605-612